本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

8.52
+0.12001.43%
盘后8.520.00000.00%16:10 EST
成交量:62.60万
成交额:532.80万
市值:5.85亿
市盈率:-4.72
高:8.76
开:8.39
低:8.19
收:8.40
52周最高:11.54
52周最低:2.86
股本:6,863.43万
流通股本:3,964.53万
量比:0.63
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-1.8064
每股收益(LYR):-2.2041
净资产收益率:-59.22%
总资产收益率:-34.41%
市净率:1.90
市盈率(LYR):-3.87

数据加载中...

2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities